Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

A novel potential effective strategy for enhancing the antitumor immune response in breast cancer patients using a viable cancer cell-dendritic cell-based vaccine.

Abdellateif MS, Shaarawy SM, Kandeel EZ, El-Habashy AH, Salem ML, El-Houseini ME.

Oncol Lett. 2018 Jul;16(1):529-535. doi: 10.3892/ol.2018.8631. Epub 2018 May 4.

2.

Loading of doxorubicin and thymoquinone with F2 gel nanofibers improves the antitumor activity and ameliorates doxorubicin-associated nephrotoxicity.

Zidan AA, El-Ashmawy NE, Khedr EG, Ebeid EM, Salem ML, Mosalam EM.

Life Sci. 2018 Aug 15;207:461-470. doi: 10.1016/j.lfs.2018.06.008. Epub 2018 Jun 6.

PMID:
29885348
3.

Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.

Koo HY, El-Baz LM, House S, Cilvik SN, Dorry SJ, Shoukry NM, Salem ML, Hafez HS, Dulin NO, Ornitz DM, Guzy RD.

J Pathol. 2018 Jun 6. doi: 10.1002/path.5106. [Epub ahead of print]

PMID:
29873400
4.

Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells.

Johnson CB, May BR, Riesenberg BP, Suriano S, Mehrotra S, Garrett-Mayer E, Salem ML, Jeng EK, Wong HC, Paulos CM, Wrangle JM, Cole DJ, Rubinstein MP.

Cancer Res. 2018 Jun 1;78(11):3067-3074. doi: 10.1158/0008-5472.CAN-17-2153. Epub 2018 Apr 10.

PMID:
29636345
5.

Hb Moscva [β24(B6)Gly→Asp (GGT>GAT), HBB: c.74G>A]: An Unstable Hemoglobin Newly Detected as a De Novo Mutation in a Mauritanian Patient.

Ghaber SM, Trabelsi N, Salem ML, Haddad F, Abba A, Darragi I, Abbes S.

Hemoglobin. 2018 Jan;42(1):7-10. doi: 10.1080/03630269.2018.1428620. Epub 2018 Mar 22.

PMID:
29564956
6.

Ethnicity influences breast cancer stem cells' drug resistance.

Kamal M, Nafie EHO, Elsers S, Alanwar S, Ibrahim R, Farag F, Mlees M, Simões BM, Spence K, Santiago-Gómez A, Salem ML, Clarke RB.

Breast J. 2018 Jul;24(4):701-703. doi: 10.1111/tbj.13021. Epub 2018 Mar 2. No abstract available.

PMID:
29498455
7.

Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia.

Salem ML, El-Shanshory MR, Abdou SH, Attia MS, Sobhy SM, Zidan MF, Zidan AA.

Immunopharmacol Immunotoxicol. 2018 Apr;40(2):158-167. doi: 10.1080/08923973.2018.1424897. Epub 2018 Feb 1.

PMID:
29388481
8.

Higher Activities of Hepatic Versus Splenic CD8+ T Cells in Responses to Adoptive T Cell Therapy and Vaccination of B6 Mice with MHC Class-1 Binding Antigen.

Salem ML, E El Naggar R, A El Naggar S, A Mobasher M, H Mahmoud M, Badr G.

Iran J Allergy Asthma Immunol. 2017 Dec;16(6):537-553.

9.

Does the mosquito Culex pipiens represent a potential vector of hepatitis C virus?

El-Kholy SE, El-Husseiny IM, Meshrif WS, El-Azm AA, Salem ML.

Med Vet Entomol. 2018 Jun;32(2):155-161. doi: 10.1111/mve.12288. Epub 2017 Dec 14.

PMID:
29239006
10.

High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients.

Elwan N, Salem ML, Kobtan A, El-Kalla F, Mansour L, Yousef M, Al-Sabbagh A, Zidan AA, Abd-Elsalam S.

Immunol Invest. 2018 Feb;47(2):169-180. doi: 10.1080/08820139.2017.1407787. Epub 2017 Nov 28.

PMID:
29182438
11.

Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.

El-Ashmawy NE, Khedr EG, Ebeid EM, Salem ML, Zidan AA, Mosalam EM.

Eur J Pharm Sci. 2017 Nov 15;109:525-532. doi: 10.1016/j.ejps.2017.09.012. Epub 2017 Sep 7.

PMID:
28890201
12.

Synergistic combination of murine bone marrow-derived dendritic cells loaded ex vivo with whole tumor lysate and systemic chemotherapy mediates antitumor immune responses in vivo.

Salem ML, Nassef M, Gomaa S, Essa I.

Biomed Pharmacother. 2017 Sep;93:286-295. doi: 10.1016/j.biopha.2017.06.046. Epub 2017 Jun 23.

PMID:
28648976
13.

IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS.

Salem ML, Zidan AA, Attia M, El-Naggar RE, Nassef M, Abou El-Azm AR, El-Bate H, Yussif M, Galal S, Abo Senna M, El Demellawy M.

Immunopharmacol Immunotoxicol. 2017 Aug;39(4):188-198. doi: 10.1080/08923973.2017.1320670. Epub 2017 May 4.

PMID:
28472907
14.

Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.

Mehrotra S, Britten CD, Chin S, Garrett-Mayer E, Cloud CA, Li M, Scurti G, Salem ML, Nelson MH, Thomas MB, Paulos CM, Salazar AM, Nishimura MI, Rubinstein MP, Li Z, Cole DJ.

J Hematol Oncol. 2017 Apr 7;10(1):82. doi: 10.1186/s13045-017-0459-2.

15.

Anti-fibrotic potential of human umbilical cord mononuclear cells and mouse bone marrow cells in CCl4- induced liver fibrosis in mice.

Elmahdy NA, Sokar SS, Salem ML, Sarhan NI, Abou-Elela SH.

Biomed Pharmacother. 2017 May;89:1378-1386. doi: 10.1016/j.biopha.2017.03.007. Epub 2017 Mar 19.

PMID:
28320105
16.

[Antibiotic susceptibility of community-acquired strains ofstaphylococcus aureus in Nouakchott Region (Mauritania)].

Salem ML, Ghaber SM, Baba SE, Maouloud MM.

Pan Afr Med J. 2016 Jul 27;24:276. doi: 10.11604/pamj.2016.24.276.9865. eCollection 2016. French.

17.

[Severe hemorrhagic forms of Rift Valley fever: about 5 cases].

Salem ML, Baba Sel W, Fall-Malick FZ, Boushab BM, Ghaber SM, Mokhtar A.

Pan Afr Med J. 2016 May 24;24:73. doi: 10.11604/pamj.2016.24.73.9573. eCollection 2016. French.

18.

Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia.

Elmaadawi IH, Mohamed BM, Ibrahim ZAS, Abdou SM, El Attar YA, Youssef A, Shamloula MM, Taha A, Metwally HG, El Afandy MM, Salem ML.

J Dermatolog Treat. 2018 Aug;29(5):431-440. doi: 10.1080/09546634.2016.1227419. Epub 2018 Mar 6.

PMID:
27553744
19.

Effect of administration timing of postchemotherapy granulocyte colony-stimulating factor on host-immune cell recovery and CD8+ T-cell response.

Salem ML, Nassef M, Abdel Salam SG, Zidan A, Mahmoud MH, Badr G, Rubinstein M, Cole D.

J Immunotoxicol. 2016 Nov;13(6):784-792. Epub 2016 Jul 15.

20.

In vitro and in vivo antitumor effects of the Egyptian scorpion Androctonus amoreuxi venom in an Ehrlich ascites tumor model.

Salem ML, Shoukry NM, Teleb WK, Abdel-Daim MM, Abdel-Rahman MA.

Springerplus. 2016 May 10;5:570. doi: 10.1186/s40064-016-2269-3. eCollection 2016.

21.

Acute inflammation induces immunomodulatory effects on myeloid cells associated with anti-tumor responses in a tumor mouse model.

Salem ML, Attia ZI, Galal SM.

J Adv Res. 2016 Mar;7(2):243-53. doi: 10.1016/j.jare.2015.06.001. Epub 2015 Jun 19.

22.

Bone marrow mononuclear cells enhance anti-inflammatory effects of pravastatin against isoproterenol-induced myocardial infarction in rats.

El-Mahdy N, Salem ML, El-Sayad M, El-Desouky KI, Zaghow N.

J Immunotoxicol. 2016 May;13(3):393-402. doi: 10.3109/1547691X.2015.1111959. Epub 2015 Nov 25.

PMID:
26606075
23.

Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy.

Salem ML, El-Badawy A.

World J Hepatol. 2015 Oct 18;7(23):2449-58. doi: 10.4254/wjh.v7.i23.2449. Review.

24.

IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells.

Andrijauskaite K, Suriano S, Cloud CA, Li M, Kesarwani P, Stefanik LS, Moxley KM, Salem ML, Garrett-Mayer E, Paulos CM, Mehrotra S, Kochenderfer JN, Cole DJ, Rubinstein MP.

Cancer Gene Ther. 2015 Jul;22(7):360-7. doi: 10.1038/cgt.2015.28. Epub 2015 Jul 17.

25.

Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells.

Rubinstein MP, Su EW, Suriano S, Cloud CA, Andrijauskaite K, Kesarwani P, Schwartz KM, Williams KM, Johnson CB, Li M, Scurti GM, Salem ML, Paulos CM, Garrett-Mayer E, Mehrotra S, Cole DJ.

Cancer Immunol Immunother. 2015 May;64(5):539-49. doi: 10.1007/s00262-015-1655-y. Epub 2015 Feb 13.

26.

Immunobiology and signaling pathways of cancer stem cells: implication for cancer therapy.

Salem ML, El-Badawy AS, Li Z.

Cytotechnology. 2015 Oct;67(5):749-59. doi: 10.1007/s10616-014-9830-0. Epub 2014 Dec 17.

27.

Autologous transplantation of CD34(+) bone marrow derived mononuclear cells in management of non-reconstructable critical lower limb ischemia.

Ismail AM, Abdou SM, Aty HA, Kamhawy AH, Elhinedy M, Elwageh M, Taha A, Ezzat A, Salem HA, Youssif S, Salem ML.

Cytotechnology. 2016 Aug;68(4):771-81. doi: 10.1007/s10616-014-9828-7. Epub 2014 Dec 16.

28.

The use of dendritic cells for peptide-based vaccination in cancer immunotherapy.

Salem ML.

Methods Mol Biol. 2014;1139:479-503. doi: 10.1007/978-1-4939-0345-0_37. Review.

PMID:
24619701
29.

G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responses.

Rubinstein MP, Salem ML, Doedens AL, Moore CJ, Chiuzan C, Rivell GL, Cole DJ, Goldrath AW.

J Hematol Oncol. 2013 Oct 1;6:75. doi: 10.1186/1756-8722-6-75.

30.

Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: role of CD62L.

Díaz-Montero CM, Zidan AA, Pallin MF, Anagnostopoulos V, Salem ML, Wieder E, Komanduri K, Montero AJ, Lichtenheld MG.

Immunol Res. 2013 Dec;57(1-3):23-33. doi: 10.1007/s12026-013-8456-1.

PMID:
24218360
31.

Immunomodulatory effects of IL-12 released from poly-N-acetyl glucosamine gel matrix during schistosomiasis infection.

Salem ML, Shoukry NM, Zidan AA, Vournakis J.

Cytotechnology. 2014 Aug;66(4):667-75. doi: 10.1007/s10616-013-9620-0. Epub 2013 Jul 26.

32.

Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects.

Faris MA, Kacimi S, Al-Kurd RA, Fararjeh MA, Bustanji YK, Mohammad MK, Salem ML.

Nutr Res. 2012 Dec;32(12):947-55. doi: 10.1016/j.nutres.2012.06.021. Epub 2012 Oct 4.

PMID:
23244540
33.

Hb S [β6(A3)Glu→Val, GAG>GTG] and β-globin gene cluster haplotype distribution in Mauritania.

Veten FM, Abdelhamid IO, Meiloud GM, Ghaber SM, Salem ML, Abbes S, Houmeida AO.

Hemoglobin. 2012;36(4):311-5. doi: 10.3109/03630269.2012.688782. Epub 2012 May 24.

PMID:
22625666
34.

Correlation of viral load with bone marrow and hematological changes in pale patients with chronic hepatitis C virus.

Abou El Azm AR, El-Bate H, Abo-Ali L, Mansour N, Ghoraba H, Salem ML.

Arch Virol. 2012 Aug;157(8):1579-86. doi: 10.1007/s00705-012-1321-z. Epub 2012 May 9.

PMID:
22569886
35.

Kinetics of rebounding of lymphoid and myeloid cells in mouse peripheral blood, spleen and bone marrow after treatment with cyclophosphamide.

Salem ML, Al-Khami AA, El-Nagaar SA, Zidan AA, Al-Sharkawi IM, Marcela Díaz-Montero C, Cole DJ.

Cell Immunol. 2012 Mar-Apr;276(1-2):67-74. doi: 10.1016/j.cellimm.2012.03.010. Epub 2012 Apr 11.

36.

The use of growth factors to modulate the activities of antigen-specific CD8+ T cells in vitro.

Alenzi FQ, Alenazi FA, Al-Kaabi Y, Salem ML.

J Med Life. 2011 Nov 14;4(4):399-406. Epub 2011 Nov 24.

37.

Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host.

Rubinstein MP, Cloud CA, Garrett TE, Moore CJ, Schwartz KM, Johnson CB, Craig DH, Salem ML, Paulos CM, Cole DJ.

J Am Coll Surg. 2012 Apr;214(4):700-7; discussion 707-8. doi: 10.1016/j.jamcollsurg.2011.12.034. Epub 2012 Feb 22.

38.

Cellular and molecular aspects of Goodpasture syndrome.

Alenzi FQ, Salem ML, Alenazi FA, Wyse RK.

Iran J Kidney Dis. 2012 Jan;6(1):1-8. Review.

39.

Apoptotic proteins and cancer: many faces.

Alenzi FQ, Salem ML, Alyaqoub FS, Alanazi FG, Alanazi WG, Alanazi MG, Alanazi AG, Alanazi MG, Al-Shehri H, Abuderman AA, Tamimi W.

J Ayub Med Coll Abbottabad. 2012 Jan-Mar;24(1):111-5. Review. No abstract available.

PMID:
23855111
40.

Defining the critical hurdles in cancer immunotherapy.

Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, Carson WE, Chang AE, Characiejus D, Choudhury AR, Coukos G, de Gruijl T, Dillman RO, Dolstra H, Dranoff G, Durrant LG, Finke JH, Galon J, Gollob JA, Gouttefangeas C, Grizzi F, Guida M, Håkansson L, Hege K, Herberman RB, Hodi FS, Hoos A, Huber C, Hwu P, Imai K, Jaffee EM, Janetzki S, June CH, Kalinski P, Kaufman HL, Kawakami K, Kawakami Y, Keilholtz U, Khleif SN, Kiessling R, Kotlan B, Kroemer G, Lapointe R, Levitsky HI, Lotze MT, Maccalli C, Maio M, Marschner JP, Mastrangelo MJ, Masucci G, Melero I, Melief C, Murphy WJ, Nelson B, Nicolini A, Nishimura MI, Odunsi K, Ohashi PS, O'Donnell-Tormey J, Old LJ, Ottensmeier C, Papamichail M, Parmiani G, Pawelec G, Proietti E, Qin S, Rees R, Ribas A, Ridolfi R, Ritter G, Rivoltini L, Romero PJ, Salem ML, Scheper RJ, Seliger B, Sharma P, Shiku H, Singh-Jasuja H, Song W, Straten PT, Tahara H, Tian Z, van Der Burg SH, von Hoegen P, Wang E, Welters MJ, Winter H, Withington T, Wolchok JD, Xiao W, Zitvogel L, Zwierzina H, Marincola FM, Gajewski TF, Wigginton JM, Disis ML.

J Transl Med. 2011 Dec 14;9:214. doi: 10.1186/1479-5876-9-214.

42.

Synergy of brief activation of CD8 T-cells in the presence of IL-12 and adoptive transfer into lymphopenic hosts promotes tumor clearance and anti-tumor memory.

Díaz-Montero CM, Naga O, Zidan AA, Salem ML, Pallin M, Parmigiani A, Walker G, Wieder E, Komanduri K, Cole DJ, Montero AJ, Lichtenheld MG.

Am J Cancer Res. 2011 Aug 30;1(7):882-96.

43.

Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses.

Salem ML.

Immunol Lett. 2011 Jun 30;137(1-2):9-14. doi: 10.1016/j.imlet.2011.02.019. Epub 2011 Feb 23. Review.

PMID:
21352854
44.

Poly-N-acetyl glucosamine gel matrix as a non-viral delivery vector for DNA-based vaccination.

Salem ML, Demcheva M, Gillanders WE, Cole DJ, Vournakis JN.

Anticancer Res. 2010 Oct;30(10):3889-94. Review.

45.

Using poly-N-acetyl glucosamine gel matrix to deliver IL-12 with anti-schistosomasis vaccination.

Salem ML, Attia WY, Al-Bolkiny YE, Al-Sharkawi IM, Demcheva M, Vournakis J.

J Infect Dev Ctries. 2010 Jun 3;4(5):318-28.

46.
47.

The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus.

Salem ML, El-Demellawy M, El-Azm AR.

Cell Immunol. 2010;262(2):96-104. doi: 10.1016/j.cellimm.2010.03.002. Epub 2010 Mar 6. Review.

PMID:
20338549
48.

Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells.

Salem ML, Al-Khami AA, El-Naggar SA, Díaz-Montero CM, Chen Y, Cole DJ.

J Immunol. 2010 Feb 15;184(4):1737-47. doi: 10.4049/jimmunol.0902309. Epub 2010 Jan 18.

49.

The role of caspase activation and mitochondrial depolarisation in cultured human apoptotic eosinophils.

Alenzi FQ, Alenazi BQ, Al-Anazy FH, Mubaraki AM, Salem ML, Al-Jabri AA, Lotfy M, Bamaga MS, Alrabia MW, Wyse RK.

Saudi J Biol Sci. 2010 Jan;17(1):29-36. doi: 10.1016/j.sjbs.2009.12.005.

50.

Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.

Salem ML, El-Naggar SA, Cole DJ.

Cell Immunol. 2010;261(2):134-43. doi: 10.1016/j.cellimm.2009.11.011. Epub 2009 Dec 5.

Supplemental Content

Loading ...
Support Center